Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.325 CAD | -1.04% |
|
-3.34% | -15.82% |
07/06 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
28/05 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.82% | 7.72Cr | |
-1.17% | 2.43TCr | |
+15.06% | 874.36Cr | |
+1.47% | 821.21Cr | |
-31.14% | 687.43Cr | |
+19.60% | 528.62Cr | |
+1.65% | 412.62Cr | |
-9.24% | 379.17Cr | |
-8.91% | 334.49Cr | |
+7.27% | 318.68Cr |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Announces Retirement Of 2 Board Directors, Strikes Agreement with Polar Asset Management Partners